Patents Examined by Christopher R. Tate
  • Patent number: 10251833
    Abstract: Described herein are compositions that contract and reduce pore size. The compositions of the disclosure are also useful for collagen contraction of the skin, calming skin, and reducing oil on the skin. The compositions comprise cosmetic ingredients such as glycerin; cyclopentasiloxane; polysilicone-11; pentaerythrityl tetraethylhexanoate; dipropylene glycol; methyl methacrylate crosspolymer; betaine; bis-PEG/PPG-16/PPG-16/16 PEG/16 dimethicone; Albizia julibrissin bark extract; Evodia rutaecarpa fruit extract; hydrolyzed soy flour; sea whip extract; and a dermatologically acceptable vehicle.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: April 9, 2019
    Assignee: Mary Kay Inc.
    Inventors: David Gan, Geetha Kalahasti, Lisha Van Pelt
  • Patent number: 10238704
    Abstract: Many people who suffer from anal rectal discomfort and disorders need fibrous sheet materials which are pre-moistened with a solution for improved cleansing without excessive skin irritation. The invention particularly concerns wet wipes, such as anal-rectal wipes, which comprises a solution comprising hamamelis water or witch hazel, to effectively treat anal-rectal disorders.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: March 26, 2019
    Assignee: Pfizer Inc.
    Inventors: Gary Robert Agisim, Robert Alan Friedline, Richard John Kenny
  • Patent number: 10232048
    Abstract: A bee venom composition and method for preparing such a composition. The bee venom can be placed in a base that allows it to be applied directly to the skin. Skin penetration enhancers promote percutaneous absorption to increase the speed at which the effects of the bee venom are experienced. A skin penetration enhancer is also disclosed.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: March 19, 2019
    Assignee: Divine Api-Logics, LLC
    Inventors: Harold Dean Gallaher, Amanda Jolene Hutchings
  • Patent number: 10226499
    Abstract: A composition comprising a Sanguisorbae officinalis plant extract and at least one additional plant extract selected from the group consisting of an Ailanthus altissima plant extract, a Galla rhois gallnut plant extract, a Glycyrrhiza Glabra plant extract, a Rheum palmatum plant extract and a Scutellaria baicalensis plant extract is disclosed. Compositions comprising Ailanthus altissima plant extract or Ailanthone are also disclosed.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: March 12, 2019
    Assignees: KAMEDIS LTD., BIO-FD&C CO. LTD.
    Inventors: Sharon Rozenblat, DaiHyun Jung, SangHyun Moh, SuJung Kim, JungHun Lee
  • Patent number: 10227547
    Abstract: The invention belongs to the field of traditional Chinese medicine (TCM), and in particular relates to an astragalus membranaceus seed raw oil and refined oil extracted from astragalus membranaceus seeds by using a supercritical extraction method, and to a use thereof in the preparation of health-care products. The astragalus membranaceus seed raw oil is obtained by supercritical CO2 fluid extraction on the astragalus membranaceus seeds; and the astragalus membranaceus seed refined oil is obtained by physically refining the astragalus membranaceus seed raw oil. The astragalus membranaceus seed raw oil and refined oil have the effects of preventing thrombosis and dilating blood vessels, can also prevent diseases such as atherosclerosis, hypertension, hyperglycemia and high cholesterol, and can be used as a long-term dietary health-care oil product for cardiovascular patients.
    Type: Grant
    Filed: August 15, 2013
    Date of Patent: March 12, 2019
    Inventors: Qianjin Feng, Ran Zhou, Anping Li, Sufen Liu, Jin Li, Cailing Shang
  • Patent number: 10226495
    Abstract: A composition for promoting hair growth comprises hinoki oil, red clover extract, and a peptide. The hinoki oil can comprise from about 0.01% to about 5% by weight of the composition, the red clover extract can comprise from about 1 ppmw to about 1,000 ppmw of the composition, and the peptide can comprise from about 0.01 ppmw to about 500 ppmw of the composition.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: March 12, 2019
    Assignee: The Beauty Cartel, LLC.
    Inventors: Denny Esco Stottlemyre, Ronald Dale Reynolds
  • Patent number: 10220067
    Abstract: The invention provides a method for extracting active therapeutic components from plant materials of the Cyclanthera pedata plant which comprises immersing said plant material containing active components and selected from the group consisting of fruits, flowers, leaves, stems, twigs, bark, wood, buds, seeds, roots, and pods in a solvent for a period of time of about 30 minutes to about 10 hours to achieve transfer of active components from the plant material to the solvent, separating the solvent containing active components from the plant material, and evaporating or distilling the solvent to produce a concentrated fraction containing active components. The invention further includes compositions and therapeutic formulations of such extracts to treat hypercholesterolemia and other high lipid related diseases.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: March 5, 2019
    Assignee: PROCAPS SA
    Inventors: Alejandro Mario Díaz Rebolledo, Carlos Perez Rebolledo
  • Patent number: 10220548
    Abstract: This invention is related to controlled release formulations of volatile antimicrobial compounds against pathogens affecting meats, plants, or plant parts or dairy products. Provided are delivery systems in the form of coatings or films, where controlled release of their volatile components in vapor form is triggered by high relative humidity. The volatile component may include, for example volatile antimicrobial liquids including low molecular weight alcohols and/or aldehydes, 1-methylcyclopropene, and/or other volatile fungicides.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: March 5, 2019
    Assignee: AgroFresh Inc.
    Inventors: Alexander Williamson, Daniel Maclean
  • Patent number: 10213467
    Abstract: The present disclosure is related to a method for improving mitochondria in a cell, comprising step of treating the cell with an extraction of Emblica officinalis, for improving ability of mitochondria to perform oxidative phosphorylation and synthesize adenosine triphosphate. The present disclosure is also related to a method for promoting proliferation of a stem cell, comprising step of treating the stem cell with an extraction of Emblica officinalis, for improving division rate of the stem cell.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: February 26, 2019
    Inventors: Han-Chung Cheng, Chi-Tang Tu, Szu-Ting Liu
  • Patent number: 10206867
    Abstract: An alcoholic extract of aerial parts of Solidago virgaurea subsp. alpestris, the method of production thereof, a cosmetic or dermatological composition containing it, as well as cosmetic and dermatological uses thereof, notably in the treatment of signs of skin ageing.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: February 19, 2019
    Inventors: Serge Holderith, Anais Tromeur, Irina Berlin, Xavier Fernandez, Alexandre Casale, Johannes Grillari, Ingo Lammermann, Florian Gruber, Marie-Sophie Narzt, Gaëlle Gendronneau
  • Patent number: 10201165
    Abstract: The present invention describes methods and formulations for protecting plants against various pathogens, involving the use of Prunus maackii materials. In some embodiments the biopesticide formulation comprises of at least one flavonoid such as 3,5,7-trihydroxy-6-methoxyflavone, 3,5,7-trihydroxy-6-methoxyflavanone or 5,7-dihydroxy-8-methoxyflavanone. The invention further provides a method of making the biopesticide by extracting a Prunus species with a solvent and formulating the composition using adjuvants, and kits for application of the biopesticide.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: February 12, 2019
    Assignee: Board of Trustees of Michigan State University
    Inventors: Raymond Hammerschmidt, Linzi Kaniszewski, Cory Outwater
  • Patent number: 10201493
    Abstract: An oral composition having a biofilm formation inhibitory action is provided. An oral composition, comprising a plant extract which is a hot water extract of Japanese mustard spinach, potherb mustard, mibuna, hot radish, cress, ostrich fern, Japanese angelica tree, or ice plant.
    Type: Grant
    Filed: March 8, 2017
    Date of Patent: February 12, 2019
    Assignee: LOTTE CO., LTD.
    Inventors: Takanori Tsugane, Shota Mohri, Yoji Saeki
  • Patent number: 10201583
    Abstract: A supplement including a blend of turmeric, quercetin and rosemary, or holy basil, wasabi, and broccoli seed extract which are present in a balanced and predetermined ratio, and which stimulate the Antioxidant Response Element (ARE), Quinone Reductase, and/or induce related gene expression, for example, heme oxygenase-1 (HMOX-1) expression. The blend of ingredients can be formed as or in a dietary supplement adapted for administration to a subject. The dietary supplement can be formulated so that the turmeric, quercetin and rosemary are present in a predetermined ratio of 1:3:5, or holy basil, wasabi, and broccoli seed extract in a predetermined ratio of 1:1:0.2. Additional ingredients can be included in the supplement. The supplement can synergistically affect natural antioxidant response pathways within cells of a subject to whom the supplement is administered. A related method of use is also provided.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: February 12, 2019
    Assignee: Access Business Group International LLC
    Inventors: David J. Fast, Jennifer Patterson, Arun Rajgopal, Donald J. Pusateri, Kevin W. Gellenbeck, Jeffrey Scholten, Stephen R. Missler, Russell K. Randolph, Jennifer Chuang, Yumei Lin, Valiantsina Kazlova
  • Patent number: 10195242
    Abstract: The invention features therapeutic compounds useful for the treatment of skin diseases (e.g., psoriasis and eczema), infections (microbial, viral, and fungal), and wounds (e.g., cuts and burns). The compounds of the invention include therapeutically-effective amounts of L-Arginine, undecylenic acid, and Rheum Officinale extract. The invention further provides for the administration of the therapeutic compounds to a patient (e.g., a human) suffering from a skin disease, infection, or wound.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: February 5, 2019
    Assignee: Wintermute Biomedical, Inc.
    Inventors: Weston J. Hale, Thomas F. Rau
  • Patent number: 10194657
    Abstract: Antimicrobial compositions providing synergistic antimicrobial effects against a variety of bacterial, viral and fungal organisms are described. Methods for using the antimicrobial compositions and products containing the antimicrobial compositions are also described herein.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: February 5, 2019
    Inventors: Joseph Paul Thomas, Zsolt Istvan Hertelendy, Michael Lisle Howell
  • Patent number: 10195240
    Abstract: Provided is a composition for preventing or treating oxidative brain injury and brain dysfunction including an extract of Astragali Radix and Salvia Miltiorrhizae Radix as an active ingredient, the composition having a highly outstanding preventive or therapeutic effect in animal models simulating brain-tissue damage and brain dysfunction induced by acute and long-term excessive stress generated in actual clinical practice, which is effectively usable as a therapeutic agent thereof.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: February 5, 2019
    Assignee: Daejeon University Industry-University Cooperation Foundation
    Inventor: Chang Gue Son
  • Patent number: 10188595
    Abstract: A method for applying a composition to skin is disclosed. The method can include topically applying to skin a composition that includes an effective amount of Silybum marianum extract and Momordica grosvenori fruit extract, wherein the Silybum marianum extract is a hydroalcoholic extract and the Momordica grosvenori fruit extract is a hydroglycolic extract.
    Type: Grant
    Filed: March 17, 2016
    Date of Patent: January 29, 2019
    Assignee: Mary Kay Inc.
    Inventors: Tiffany Florence, Michelle Hines, David Gan
  • Patent number: 10188689
    Abstract: The invention disclosed herein relates to the use of an extract of Dodonaea viscosa in breast cancer therapy, either alone or in combination with other breast cancer therapies.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: January 29, 2019
    Inventors: Nokwanda Pearl Makunga, Anna-Mart Engelbrecht
  • Patent number: 10188688
    Abstract: There is disclosed the use of a composition for promoting neuronal growth of neurons in tissues of the central or peripheral nervous system. There is also disclosed a method for inducing proliferation or differentiation of neuronal cells.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: January 29, 2019
    Assignee: MOLEAC PTE. LTD.
    Inventors: Michel Maurice Jacques Lazdunski, Catherine Louise Heurteaux, David Picard
  • Patent number: 10188116
    Abstract: Doum nanoparticles can be synthesized by drying Doum fruit, reducing the dried Doum fruit to a powder or flour, and subjecting the powder to acid hydrolysis or alcohol hydrolysis to provide Doum nanoparticles. The Doum nanoparticles can be used as a food preservative. When compared to bulk Doum particles, the Doum nanoparticles can provide substantially increased antibacterial activity.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: January 29, 2019
    Assignee: King Saud University
    Inventors: Manal Ahmed Gasmelseed Awad, Awatif Ahmed Hendi, Khalid Mustafa Osman Ortashi, Hany Mohamed Yehia, Mohamed Mahmoud Hafez Ahmed, Hatem Salama Mohamed Ali, Mohamed Fekry Serag El-Din, Zeinab Korany Mohamed Hassan